1558 — Yichang Hec Changjiang Pharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- HK$10.75bn
- HK$11.63bn
- CNY3.72bn
- 49
- 44
- 86
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 6.31 | ||
| PEG Ratio (f) | 0.14 | ||
| EPS Growth (f) | 82.63% | ||
| Dividend Yield (f) | 7.05% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.19 | ||
| Price to Tang. Book | 1.68 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.71 | ||
| EV to EBITDA | 10.25 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.03% | ||
| Return on Equity | 5.87% | ||
| Operating Margin | 18.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 2,348.11 | 913.79 | 3,744.95 | 6,294.59 | 3,723.78 | 5,056.05 | 5,209.51 | -9.76% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -73.8 | n/a | n/a | +812.36 | -77.39 | +189.83 | +3.33 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
YiChang HEC ChangJiang Pharmaceutical Co Ltd is a China-based company primarily engaged in the development, manufacturing and sale of pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic diseases. The Company's main products include Kewei (Oseltamivir Phosphate Capsules and Granules), Ertongshu (Benzbromarone Tablets), Oumeining (Telmisartan Tablets), Linluoxing (Moxifloxacin Hydrochloride Tablets) and Olmesartan Tablets and other products. The Company is also engaged in the centralized procurement business. The Company mainly conducts its business in the domestic market.
Directors
- Xinfa Tang NEC (51)
- Qiang Zhang CFO (43)
- Juncai Jiang GMG (33)
- Shuang Li DGM (35)
- Danjin Wang DGM (45)
- Yangui Chen EDR (35)
- Wing Shan Ng SEC
- Qiyun Peng SEC
- Eddy Huang NED
- Xuechen Li NID
- Jianxin Tang NID (55)
- Ling Xiang NID
- Dayao Zhao NID
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 8th, 2001
- Public Since
- December 29th, 2015
- No. of Employees
- 4,861
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 879,967,700
- Address
- Zhen An Road No. 368, DONGGUAN, 443300
- Web
- https://www.hec-changjiang.com/
- Phone
- +86 76981768866
- Auditors
- KPMG
Upcoming Events for 1558
YiChang HEC ChangJiang Pharmaceutical Co Ltd Annual Shareholders Meeting
Half Year 2025 YiChang HEC ChangJiang Pharmaceutical Co Ltd Earnings Release
Similar to 1558
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Yichang Hec Changjiang Pharmaceutical Co share price?
As of Today at 21:03 UTC, shares in Yichang Hec Changjiang Pharmaceutical Co are trading at HK$12.20. This share price information is delayed by 15 minutes.
How has the Yichang Hec Changjiang Pharmaceutical Co share price performed this year?
Shares in Yichang Hec Changjiang Pharmaceutical Co last closed at HK$12.20 and the price had moved by -2.4% over the past 365 days. In terms of relative price strength the Yichang Hec Changjiang Pharmaceutical Co share price has underperformed the FTSE Developed Asia Pacific Index by -1.29% over the past year.
What are the analyst and broker recommendations for Yichang Hec Changjiang Pharmaceutical Co?
The overall consensus recommendation for Yichang Hec Changjiang Pharmaceutical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Yichang Hec Changjiang Pharmaceutical Co dividend yield?
Yichang Hec Changjiang Pharmaceutical Co does not currently pay a dividend.
Does Yichang Hec Changjiang Pharmaceutical Co pay a dividend?
Yichang Hec Changjiang Pharmaceutical Co does not currently pay a dividend.
When does Yichang Hec Changjiang Pharmaceutical Co next pay dividends?
Yichang Hec Changjiang Pharmaceutical Co does not currently pay a dividend.
How do I buy Yichang Hec Changjiang Pharmaceutical Co shares?
To buy shares in Yichang Hec Changjiang Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Yichang Hec Changjiang Pharmaceutical Co?
As of the previous close price of HK$12.20, shares in Yichang Hec Changjiang Pharmaceutical Co had a market capitalisation of HK$10.75bn.
Where are Yichang Hec Changjiang Pharmaceutical Co shares listed?
Here are the trading details for Yichang Hec Changjiang Pharmaceutical Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1558
What kind of share is Yichang Hec Changjiang Pharmaceutical Co?
Based on an overall assessment of its quality, value and momentum Yichang Hec Changjiang Pharmaceutical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Yichang Hec Changjiang Pharmaceutical Co share price forecast for 2025?
The analyst consensus target price for shares in Yichang Hec Changjiang Pharmaceutical Co is HK$12.57. That is 3.04% above the last closing price of HK$12.20.
Analysts covering Yichang Hec Changjiang Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of CNY1.80 for the next financial year.
Find out moreWhat is the trend in the Yichang Hec Changjiang Pharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Yichang Hec Changjiang Pharmaceutical Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +41.13%.
As of the last closing price of HK$12.20, shares in Yichang Hec Changjiang Pharmaceutical Co were trading +28.29% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Yichang Hec Changjiang Pharmaceutical Co PE Ratio?
The Yichang Hec Changjiang Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 6.31. The shares last closed at HK$12.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Yichang Hec Changjiang Pharmaceutical Co?
Yichang Hec Changjiang Pharmaceutical Co's management team is headed by:
- Xinfa Tang - NEC
- Qiang Zhang - CFO
- Juncai Jiang - GMG
- Shuang Li - DGM
- Danjin Wang - DGM
- Yangui Chen - EDR
- Wing Shan Ng - SEC
- Qiyun Peng - SEC
- Eddy Huang - NED
- Xuechen Li - NID
- Jianxin Tang - NID
- Ling Xiang - NID
- Dayao Zhao - NID